慢性病患者智慧健康管理模式的构建与应用研究

注册号:

Registration number:

ChiCTR1800020273 

最近更新日期:

Date of Last Refreshed on:

2018-12-21 23:14:42 

注册时间:

Date of Registration:

2018-12-21 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

慢性病患者智慧健康管理模式的构建与应用研究

Public title:

Construction and application of smart health management for patients with chronic illness

注册题目简写:

English Acronym:

研究课题的正式科学名称:

慢性病患者智慧健康管理模式的构建与应用研究

Scientific title:

Construction and application of smart health management for patients with chronic illness

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

蒋文慧 

研究负责人:

蒋文慧 

Applicant:

JIANG WENHUI 

Study leader:

JIANG WENHUI 

申请注册联系人电话:

Applicant telephone:

+86 18710312826

研究负责人电话:

Study leader's
telephone:

+86 18710312826

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

jiangwenhui@mail.xjtu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

jwhfq@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国陕西省西安市雁塔西路76号

研究负责人通讯地址:

中国陕西省西安市雁塔西路76号

Applicant address:

76 Yanta Road West, Yanta District, Xi'an, Shaanxi, China

Study leader's address:

76 Yanta Road West, Yanta District, Xi'an, Shaanxi, China

申请注册联系人邮政编码:

Applicant postcode:

710061

研究负责人邮政编码:

Study leader's postcode:

710061

申请人所在单位:

西安交通大学

Applicant's institution:

Xi'an Jiaotong University

研究负责人所在单位:

西安交通大学

Affiliation of the Leader:

Xi'an Jiaotong University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2018-515

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

西安交通大学医学部生物医学伦理委员会

Name of the ethic committee:

Ethics Board of Xi'an Jiaotong University

伦理委员会批准日期:

Date of approved by ethic committee:

2018-08-01 00:00:00

伦理委员会联系人:

陈腾

Contact Name of the ethic committee:

CHEN TENG

伦理委员会联系地址:

中国陕西省西安市雁塔西路76号西安交通大学医学中心

Contact Address of the ethic committee:

Xian Jiaotong University Health Science Center, 76 Yanta Road West, Yanta District, Xi'an, Shaanxi, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

西安交通大学

Primary sponsor:

Xi'an Jiaotong University

研究实施负责(组长)单位地址:

中国陕西省西安市雁塔西路76号

Primary sponsor's address:

76 Yanta Road West, Yanta District, Xi'an, Shaanxi, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西

市(区县):

西安

Country:

China

Province:

Shaanxi

City:

Xi'an

单位(医院):

西安交通大学

具体地址:

中国陕西省西安市雁塔西路76号

Institution
hospital:

Xi'an Jiaotong University

Address:

76 Yanta Road West, Yanta District, Xi'an, Shaanxi, China

经费或物资来源:

国家社会科学基金(18BGL248)

Source(s) of funding:

National Social Science Fund of China (Number:18BGL248)

研究疾病:

高血压、糖尿病、冠心病  

Target disease:

Hypertension; Diabetes; Coronary Heart Diease

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

卫生服务研究 

Study phase:

Health Services Research

研究设计:

整群随机分组 

Study design:

Cluster randomization 

研究目的:

本研究基于WHO提出的创新性慢性病管理框架(ICCC)为理论基础,构建慢性病患者智慧健康管理模式并试点应用。具体目标包括:1)评估慢性病患者生活质量、自我管理行为、自我效能及健康管理需求;2)发展慢性病患者智慧健康管理模式草案;3)搭建慢性病患者智慧健康管理平台;4)采用随机对照研究在西安试点应用,以RE-AIM理论框架评价慢性病患者智慧健康管理模式的效能。以期为探索适合我国国情的“广覆盖、高效益、低成本”的慢性病健康管理模式提供新的思路,亦为政府制定相关的卫生政策提供参考。  

Objectives of Study:

The goal of this program is to develop, deliver and evaluate smart health management for patients with chronic illness, based on innovative chronic disease management framework (ICCC) proposed by WHO. Specific objectives include: 1) To assess the quality of life, self-management behaviors, self-efficacy and health management needs of patients with chronic illness; 2) To develop smart health management protocols for patients with chronic illness; 3) To establish smart health management platform with the assistance of IT specialist4) To evaluate the effectiveness and efficiency of smart health management for patients with chronic illness based on the RE-AIM theoretical framework. Moreover, we can generate evidence for informing policy to improve chronic illnesses management by demonstrating Broad Coverage, Low costs and High Efficiency.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

A.患者有严重精神认知疾病;
B.有严重并发症者。

Exclusion criteria:

Patients with documented cognitive impairments or severe medical complications

研究实施时间:

Study execute time:

From 2019-01-01 00:00:00 To 2021-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2019-01-01 00:00:00 To 2021-12-31 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

108

Group:

Group 2

Sample size:

干预措施:

智慧健康管理

干预措施代码:

Intervention:

Smart health management

Intervention code:

组别:

对照组

样本量:

108

Group:

Group 1

Sample size:

干预措施:

传统健康管理

干预措施代码:

Intervention:

Traditional health management

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

陕西 

市(区县):

西安 

Country:

China

Province:

Shaanxi

City:

Xian

单位(医院):

社区卫生中心 

单位级别:

社区卫生中心 

Institution
hospital:

Community healt care center

Level of the institution:

Health care center in Communities

国家:

中国

省(直辖市):

陕西 

市(区县):

西安 

Country:

China

Province:

Shaanxi

City:

Xian

单位(医院):

西安交通大学第一附属医院 

单位级别:

三甲医院 

Institution
hospital:

First Affiliated Hospital of Xian Jiaotong University

Level of the institution:

Tertiary Hospital

测量指标:

Outcomes:

指标中文名:

生活质量

指标类型:

主要指标

Outcome:

quality of life

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

慢性病自我管理行为

指标类型:

主要指标

Outcome:

self-managem behaviors

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

慢性病自我效能

指标类型:

主要指标

Outcome:

self-efficacy

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

临床指标(患者病历)

指标类型:

主要指标

Outcome:

Clinical index from medical records

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NO

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Grouping by random number table

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

Revman

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Revman

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1. 病历记录表 2. 调查问卷 3. 电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

1. Medical Record Form 2. Questionnaire 2. Electronic Data Capture

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2018-12-21 23:14:42